Serafin Andrew

Serafin Andrew is listed in filings as CHIEF STRATEGY OFFICER at Harmony Biosciences Holdings, Inc.. This profile follows SEC Form 4 activity through Jan 26, 2026, including 10 public disclosures. Recent filings connect the profile to Harmony Biosciences Holdings, Inc. (HRMY). The current snapshot covers public activity from Jan 28, 2025 to Jan 26, 2026. Reported amounts are shown as $32.9K to $41.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.